Kieuhoa Tran Vo MD
Associate Professor, Pediatrics, UCSF School of Medicine
1825 4th Sreet6TH floorSan Francisco, CA 94143
Fax+1 415-353-2657
Overview of Dr. Vo
Dr. Kieuhoa Vo is a pediatric hematologist/oncologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Benioff Children's Hospital Oakland and UCSF Benioff Childrens Hospital. She received her medical degree from Indiana University School of Medicine and has been in practice 18 years. She is one of 54 doctors at UCSF Benioff Children's Hospital Oakland and one of 21 doctors at UCSF Benioff Childrens Hospital who specialize in Pediatric Hematology & Oncology. She has more than 30 publications and over 500 citings.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2012 - 2015
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2008 - 2011
Indiana University School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2012 - 2028
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE Start of enrollment: 2021 Aug 28
Roles: Contact
- NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial Start of enrollment: 2024 Dec 16
Roles: Contact
- Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) Start of enrollment: 2018 Nov 14
Publications & Presentations
PubMed
- A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.David S Shulman, Kieuhoa T Vo, Frank M Balis, Holly Lindsay, Bradley D DeNardo
Clinical Cancer Research. 2026-05-26 - Clinical and Biological Features of Response in Resistant Neuroblastoma toI-Metaiodobenzylguanidine Radiotherapy in the Anti-GD2 Immunotherapy Era.Benjamin J Lerman, Katherine K Matthay, Fabienne Hollinger, Catriona Black, Ann A Lazar
Pediatric Blood & Cancer. 2026-05-12 - Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study.Daniel A Morgenstern, Giuseppe Barone, Nadege Corradini, Sara M Federico, Christian Flotho
Pediatric Blood & Cancer. 2026-05-01
Grant Support
- Circulating biomarkers of clinical response to combination targeted therapies in neuroblastomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Circulating biomarkers of clinical response to combination targeted therapies in neuroblastomaNIH/NCI2024–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
